These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3134208

  • 21. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
    Feld R, DePauw B, Berman S, Keating A, Ho W.
    J Clin Oncol; 2000 Nov 01; 18(21):3690-8. PubMed ID: 11054442
    [Abstract] [Full Text] [Related]

  • 22. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.
    Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J.
    N Engl J Med; 1986 Aug 28; 315(9):552-8. PubMed ID: 3526155
    [Abstract] [Full Text] [Related]

  • 23. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
    Höffken G, Pasold R, Pflüger KH, Finke J, Fauser AA, Szelenyi H, Wagner J.
    J Antimicrob Chemother; 1999 Sep 28; 44(3):367-76. PubMed ID: 10511404
    [Abstract] [Full Text] [Related]

  • 24. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.
    Fleischhack G, Hartmann C, Simon A, Wulff B, Havers W, Marklein G, Hasan C, Bode U.
    J Antimicrob Chemother; 2001 Jun 28; 47(6):841-53. PubMed ID: 11389117
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR, Vandercam B, Louie T, Runde V, Norberg B, Anniko M, Andrien F, Baudrihaye M, Bow E, Burman LA.
    Scand J Infect Dis Suppl; 1987 Jun 28; 52():65-78. PubMed ID: 3331044
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
    Fainstein V, Bodey GP, Elting L, Bolivar R, Keating MJ, McCredie KB, Valdivieso M.
    J Antimicrob Chemother; 1983 Jul 28; 12 Suppl A():101-10. PubMed ID: 6352612
    [Abstract] [Full Text] [Related]

  • 30. Three-step empiric treatment for severely neutropenic patients with fever: ceftazidime--vancomycin--amphotericin B.
    Koeppler H, Pflueger KH, Seitz R, Havemann K.
    Infection; 1989 Jul 28; 17(3):142-5. PubMed ID: 2661438
    [Abstract] [Full Text] [Related]

  • 31. A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
    Lim SH, Smith MP, Goldstone AH, Machin SJ.
    Br J Haematol; 1990 Dec 28; 76 Suppl 2():41-4. PubMed ID: 2149051
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ceftazidime as a single agent in the management of children with fever and neutropenia.
    Morgan G, Duerden BI, Lilleyman JS.
    J Antimicrob Chemother; 1983 Jul 28; 12 Suppl A():347-51. PubMed ID: 6352641
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children.
    Jacobs RF, Vats TS, Pappa KA, Chaudhary S, Kletzel M, Becton DL.
    Infection; 1993 Jul 28; 21(4):223-8. PubMed ID: 8225625
    [Abstract] [Full Text] [Related]

  • 38. Antibiotic therapy in cancer patients with fever and neutropenia.
    N Engl J Med; 1987 Feb 12; 316(7):410-2. PubMed ID: 3543678
    [No Abstract] [Full Text] [Related]

  • 39. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
    Hung KC, Chiu HH, Tseng YC, Wang JH, Lin HC, Tsai FJ, Peng CT.
    J Microbiol Immunol Infect; 2003 Dec 12; 36(4):254-9. PubMed ID: 14723254
    [Abstract] [Full Text] [Related]

  • 40. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.
    Ramphal R, Bolger M, Oblon DJ, Sherertz RJ, Malone JD, Rand KH, Gilliom M, Shands JW, Kramer BS.
    Antimicrob Agents Chemother; 1992 May 12; 36(5):1062-7. PubMed ID: 1510394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.